Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

Among the more unconventional options for treating long COVID, nicotine – delivered via low-dose transdermal patches – has ...

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to ...

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...